Published summary: 2026-03-07
Where the evidence converges
Meta-analysis of 9 studies found cannabis nearly doubles motor vehicle crash risk (OR 1
Strong evidence · 18 studies
High heterogeneity between studies. Observational designs cannot prove causation. Different studies used different measures of cannabis exposure (blood THC vs self-report). Publication bias was possib
A meta-analysis of 80 studies found THC impairs driving-related skills at peak effect, with impairment from inhaled cannabis generally resolving within 3-5 hours
Strong evidence · 18 studies
Laboratory and simulated driving conditions may not fully replicate real-world driving. Most studies used moderate, controlled doses. Individual variation in tolerance and metabolism is not captured.
Meta-analysis of 28 studies found blood and saliva THC levels are poor predictors of driving impairment, with negligible to weak correlations that disappear entirely in regular cannabis users
Strong evidence · 18 studies
Analyses in regular users were less robust due to fewer studies. Most studies used simulated rather than real-world driving.
Where questions remain
Among 600 drivers killed in single-vehicle crashes, alcohol was detected in 79
Moderate evidence · 55 studies
Detection of THC in blood does not prove impairment at the time of the crash. THC metabolites clear the blood relatively quickly, so some cannabis-impaired drivers may have tested negative. The study
THCV-COOH, a urinary metabolite unique to natural marijuana, reliably distinguished marijuana use from prescription Marinol use in a controlled crossover study
Moderate evidence · 55 studies
Only four subjects. THCV content varies among marijuana varieties, so very low-THCV marijuana might not produce detectable THCV-COOH. The study predates the availability of many modern cannabis produc
European review found illicit drug prevalence of 1-5% among drivers, with cannabis among the top substances of concern
Moderate evidence · 55 studies
The review focused on the Finnish and European context, which may not generalize to other regions. Data on drug prevalence among drivers varied in quality across countries. The review did not establis
Two studies in an unventilated van found passive cannabis smoke exposure only caused positive oral fluid tests when samples were collected in the smoky environment
Moderate evidence · 55 studies
The extreme exposure conditions (unventilated van with four simultaneous smokers) may not represent typical passive exposure scenarios. Only oral fluid testing was examined. The sample size of passive
Research gaps
- Long-term prospective studies tracking outcomes over 5+ years are largely absent from the literature.
- Research on diverse populations (different ages, ethnicities, and medical backgrounds) remains limited.
Key studies
Blood and Saliva THC Levels Are Poor Indicators of Driving Impairment
Many jurisdictions use blood or oral fluid THC levels to identify impaired drivers, similar to blood alcohol. This meta-analysis shows THC biomarkers are fundamentally different from blood alcohol as impairment indicators.
Roadside Oral Fluid THC Tests Are Good at Detecting Any Cannabis Use but Poor at Predicting Blood Levels
Many countries use roadside oral fluid tests to enforce cannabis-impaired driving laws. This study shows these tests are useful for identifying recent cannabis use but unreliable for determining whether drivers exceed legal blood THC limits, with major implications for enforcement fairness.
Meta-analysis of 57 studies confirmed cannabis impairs driving, comparable to low blood alcohol
This is the largest meta-analysis of experimental driving studies on cannabis to date, providing definitive evidence that cannabis impairs driving performance and that the combination with alcohol is particularly dangerous.
THC impairs driving-related skills for about 3-5 hours after inhaling, longer after eating
As cannabis legalization expands, evidence-based guidelines for how long to wait before driving are essential. This meta-analysis provides the most comprehensive synthesis to date of how long THC-related driving impairment actually lasts.
Meta-analysis: cannabis use nearly doubles motor vehicle crash risk
This was one of the most comprehensive meta-analyses of cannabis-impaired driving risk. The near-doubling of crash risk provided a clear evidence base for policy on drug-impaired driving.
Cannabis Use Linked to Higher Risk of Fatal and Injurious Car Crashes
As cannabis legalization expands globally, quantifying the crash risk associated with cannabis use is essential for setting driving policy, THC legal limits, and public education campaigns.
How the research developed
Pre-2000
4 studies published. Includes 2 RCTs.
2000–2009
9 studies published. Includes 4 RCTs, 1 strong-evidence studies.
2010–2014
22 studies published. Includes 1 meta-analyses, 6 RCTs, 2 strong-evidence studies.
2015–2019
43 studies published. Includes 6 RCTs, 10 strong-evidence studies.
2020–present
173 studies published. Includes 5 meta-analyses, 28 RCTs, 32 strong-evidence studies.
How this summary was assembled
This consensus synthesizes 251 peer-reviewed studies: 6 meta-analyses (2%), 46 randomized controlled trials (18%), 100 observational studies (40%), 39 reviews (16%), 4 case studies (2%), 56 other study types (22%). Studies span from the earliest available research through 2025. Evidence strength ratings reflect study design, sample size, and replication across multiple research groups.
These counts describe the source summary at publication. They may differ from the current library.